Skip to content

5-MeO-DMT: all studies

Page 95 of 112: studies 941 to 950 of 1,115, newest first. Back to the 5-MeO-DMT overview

Research

[Analysis of the chemical drugs among structural isomer].

Yakugaku Zasshi September 1, 2006 Kayo Doi, Maki Miyazawa, Hisashi Fujii et al.

Drugs that have a pharmacological effect similar to legal drugs such as narcotics and stimulants are available in the market and widely used. 5-methoxy-N,N-di-iso-propyl-tryptamine (5MeO-DIPT) and alpha-methyl-tryptamine (AMT) were categorized as narcotics and were specified as legal drugs in April 2005, and also 2,5-dimethoxy-4-n-propylthiophenethylamine (4C-T-7) and...

Synthesis of deuterium labeled standards of 5‐methoxy‐N,N‐dimethyltryptamine (5‐Meo‐DMT)

Journal of Labelled Compounds and Radiopharmaceuticals August 14, 2006 Ya-Zhu Xu, Chinpiao Chen 14 citations

Abstract The Batcho‐Leimgruber strategy was employed to synthesize 5‐[ 2 H 3 ]‐methoxy‐1 H ‐indole 4 from commercially available 5‐hydroxy‐2‐nitrotoluene 1 and CD 3 I. Compound 4 was treated with oxalyl chloride, dimethylamine and lithium aluminum hydride to yield 5‐[ 2 H 3 ]‐methoxy‐ N , N ‐dimethyltryptamine 6 . Copyright © 2006 John Wiley & Sons, Ltd.

DOI: 10.1002/jlcr.1109 (opens in new tab) Dimethylamine Oxalyl chloride Yield engineering Lithium medication +6

Effects of psilocybin on time perception and temporal control of behaviour in humans

Journal of Psychopharmacology May 20, 2006 Marc Wittmann, Olivia Carter, Felix Hasler et al. 245 citations

Hallucinogenic psilocybin is known to alter the subjective experience of time. However, there is no study that systematically investigated objective measures of time perception under psilocybin. Therefore, we studied dose-dependent effects of the serotonin (5-HT) 2A/1A receptor agonist psilocybin (4-phosphoryloxy-N, N-dimethyltryptamine) on temporal processing, employing tasks of temporal...

DOI: 10.1177/0269881106065859 (opens in new tab) Psilocybin Time perception Cognition Hallucinogen +4

Rhabdomyolysis after ingestion of "foxy," a hallucinogenic tryptamine derivative.

Mayo Clinic Proceedings April 1, 2006 Gheath Alatrash, Navneet S Majhail, James C Pile 108 citations

"Foxy methoxy" (chemical name, 5-methoxy-N,N-diisopropyltryptamine) is a hallucinogenic tryptamine that has been abused with increasing frequency since its appearance in the late 1990s. Like other drugs in this class, foxy frequently produces feelings of euphoria, disinhibition, and auditory as well as visual hallucinations. The drug has been linked to adverse effects, including restlessness,...

Increased frontal and paralimbic activation following ayahuasca, the pan-amazonian inebriant

Psychopharmacology March 30, 2006 Jordi Riba, Sergio Romero, Eva Grasa et al. 245 citations

RationaleAyahuasca is a South American psychoactive plant tea which contains the serotonergic psychedelic N,N-dimethyltryptamine (DMT) and monoamine-oxidase inhibitors that render DMT orally active. Previous investigations with ayahuasca have highlighted a psychotropic effect profile characterized by enhanced introspective attention, with individuals reporting altered somatic perceptions and...

Effects of the N343A mutation in TM6 of the human serotonin 5‐HT2A Receptor

The FASEB Journal March 1, 2006 Michael R Braden, James J. Chambers, David E. Nichols

The human serotonin 2A receptor (h5‐HT 2A R) plays an essential role in cognition, and is the principal target for serotonergic hallucinogens as well as atypical antipsychotics. Utilizing our in silico ‐activated h5‐HT 2A R homology model, an interaction was predicted between Asn343(6.55) in TM6 and the carbonyl of LSD. Virtual docking simulations of a new class of 5‐HT2 agonists, substituted N...

Pharmacologic analysis of non-synonymous coding h5-HT2A SNPs reveals alterations in atypical antipsychotic and agonist efficacies.

The pharmacogenomics journal 2006 M A Davies, Vincent Setola, R T Strachan et al.

The 5-HT(2A)-serotonin receptor is a major molecular target for most atypical antipsychotic drugs as well as most hallucinogens, which can exacerbate psychotic symptoms. In this study, we examined whether random sequence variations in the gene (single nucleotide polymorphisms, SNPs) encoding the 5-HT(2A)-serotonin receptor could explain inter-individual variability in atypical antipsychotic and...

Zoonotic potential of emerging animal diseases

BMJ November 24, 2005 Samson S. Y. Wong, Kwok‐Yung Yuen 2 citations

Abstract 5-Methoxy-N,N-dimethyltryptamine (acronymized as 5-MeO-DMT) is sui generis among the numerous naturally-occurring psychoactive substances due to its unparalleled ego-dissolving effects which can culminate in a state of nondual consciousness (which is phenomenologically similar to transformative peak experiences described in various ancient contemplative traditions, e.g., Advaita...

Author's reply

The British Journal of Psychiatry November 1, 2005 B. Sessa

Grof (1975Grof ( , 1990) ) has been the most Grof (1975Grof ( , 1990) ) has been the most prominent explorer of these inaccessible prominent explorer of these inaccessible regions for over 40 years and once research regions for over 40 years and once research into lysergic acid diethylamide (LSD) into lysergic acid diethylamide (LSD) became impossible, developed a technique became impossible,...

A role for psychedelics in psychiatry?

The British Journal of Psychiatry November 1, 2005 G. Edwards

Grof (1975Grof ( , 1990) ) has been the most Grof (1975Grof ( , 1990) ) has been the most prominent explorer of these inaccessible prominent explorer of these inaccessible regions for over 40 years and once research regions for over 40 years and once research into lysergic acid diethylamide (LSD) into lysergic acid diethylamide (LSD) became impossible, developed a technique became impossible,...